1. Home
  2. ARAI vs NKTX Comparison

ARAI vs NKTX Comparison

Compare ARAI & NKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ARAI

Arrive AI Inc. Common Stock

N/A

Current Price

$3.81

Market Cap

143.7M

Sector

Finance

ML Signal

N/A

Logo Nkarta Inc.

NKTX

Nkarta Inc.

HOLD

Current Price

$1.87

Market Cap

133.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARAI
NKTX
Founded
2020
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Diversified Commercial Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
143.7M
133.5M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
ARAI
NKTX
Price
$3.81
$1.87
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
5
Target Price
$12.00
$13.25
AVG Volume (30 Days)
100.2K
641.1K
Earning Date
11-14-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$98,175.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$900.00
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.03
$1.31
52 Week High
$40.00
$2.74

Technical Indicators

Market Signals
Indicator
ARAI
NKTX
Relative Strength Index (RSI) N/A 47.98
Support Level N/A $1.78
Resistance Level N/A $1.90
Average True Range (ATR) 0.00 0.07
MACD 0.00 0.02
Stochastic Oscillator 0.00 73.91

Price Performance

Historical Comparison
ARAI
NKTX

About ARAI Arrive AI Inc. Common Stock

Arrive AI Inc is a technology company. Its patented Autonomous Last Mile (ALM) platform enables secure, efficient delivery to and from a smart, AI-powered mailbox-whether by drone, ground robot, or human courier. The platform provides real-time tracking, smart logistics alerts, and advanced chain-of-custody controls to support shippers, delivery services, and autonomous networks. By combining artificial intelligence with autonomous technology, Arrive AI makes the exchange of goods between people, robots, and drones frictionless and convenient. Its system integrates with smart home devices such as doorbells, lighting, and security systems to streamline the entire last-mile delivery experience.

About NKTX Nkarta Inc.

Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.

Share on Social Networks: